Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
QD vs BID Tacrolimus and Everolimus in Liver Transplant
NCT03256864Phase 4Completed
- Sponsor
- Chang Gung Memorial Hospital
- Start
- Jan 2016
- Primary completion
- Jun 2019
- Modality
- RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of tacrolimus and everolimus in Liver transplant rejection (2 arms), sponsored by Chang Gung Memorial Hospital. Primary endpoint: Area Under the Curve at 6 months. Started Jan 2016; status: completed.
02
Drugs
tacrolimuseverolimus
03
Conditions
Liver transplant rejection
Beyond the preview
Go deeper on NCT03256864.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03256864.